FDA Commissioner Robert Califf

Analyst Reacts To FDA Commish Comments: Medical And Recreational Cannabis Could Have Separate Regulations

FDA Commissioner Robert Califf's Thursday testimony sparked new conversations about the future of cannabis in the U.S. particularly concerning its medical and recreational classifications.

FDA Commissioner To House Committee: 'There's No Reason For DEA To Delay' Cannabis Rescheduling

FDA Commissioner Robert Califf faced questions on various critical issues at a House Oversight hearing, including the rescheduling of cannabis and FDA's decision not to regulate CBD as a food and dietary supplement.